(Sr.) Manager-Medical Science Liaison-Neuroscience at Eli Lilly and Company

Tianjin, Tianjin, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Advanced degree in health (incomplete in description, but specified as minimum)

Responsibilities

Maintain and effectively communicate deep scientific knowledge in the Neuroscience therapeutic area through continuous learning to answer complex scientific questions and serve as a trusted, peer-credible resource
Excel at customer engagement by spending the majority of time field-based, conducting mutually beneficial 2-way dialogues with Scientific Experts (SEs), providing deep disease state and product information, answering questions, and connecting SEs with Lilly resources or internal partners for collaborations
Demonstrate strategic vision and leadership by synthesizing complex data from SE interactions, communicating clinical insights and unanswered questions to Lilly medical and cross-functional teams, using creative problem-solving, principle-based decision-making, cultivating internal networks, and contributing to medical planning and strategy
Demonstrate territory ownership through strategic analysis, planning, and prioritization to maximize efficiency, implementing and evaluating a strategic territory plan with personal accountability for results, and executing the role in full compliance with internal/external requirements, procedures, and laws

Skills

Neuroscience

Medical Science Liaison

Scientific Communication

Therapeutic Area Expertise

Stakeholder Engagement

KOL Management

Clinical Research

Disease Management

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free